Field evaluation of a previously untested strain of biolarvicide (Bacillus thuringiensis israelensis H14) for mosquito control in an urban area of Orissa, India

Journal of the American Mosquito Control Association

Volumn 24, Issue 3, 2008, Pages 410-414

  Sharma, S K ^a   Upadhyay, A K ^a   Haque, M A ^a   Raghavendra, K ^a   Dash, A P ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

Anopheles culicifacies; Bacillus thuringiensis israelensis serotype H 14 (VCRC B17); Culex quinquefasciatus; Larval abundance; Mosquito control

Indexed keywords

ANOPHELES CULICIFACIES; BACILLUS THURINGIENSIS; BACILLUS THURINGIENSIS SEROVAR ISRAELENSIS; CULEX PIPIENS QUINQUEFASCIATUS;

ANIMAL; ARTICLE; BACILLUS THURINGIENSIS; CITY; EVALUATION; INDIA; LARVA; MOSQUITO; POPULATION DENSITY; REPRODUCTION; SANITATION;

ANIMALS; BACILLUS THURINGIENSIS; CITIES; CULICIDAE; DRAINAGE, SANITARY; INDIA; LARVA; MOSQUITO CONTROL; POPULATION DENSITY; REPRODUCTION;

EID: 58149160066     PISSN: 8756971X     EISSN: None     Source Type: Journal    
DOI: 10.2987/5704.1     Document Type: Article

References (16)

1. Balaraman K, Hoti SL. 1987. Comparative cost of mosquito control with larvicidal bacilli and insecticides. Indian J Malariol 24:131-134.
2. Davidson EW, Sweeney ASW, Cooper R. 1981. Comparative field trials of Bacillus sphaericus strain 1593 and Bacillus thuringiensis var. israelensis commercial powder formulations. J Econ Entomol 74:350-357.
3. de Barjac H. 1990. Characterization and prospective view of Bacillus thuringiensis. In: deBarjac H, Sutherland DJ, eds. Bacterial control of mosquitoes and black flies. Piscataway, NJ: Rutgers University Press. p 10-15.
4. Dua VK, Sharma SK, Sharma VP. 1993. Application of Bactoculicide (B. thuringiensis H-14) for controlling mosquito breeding in industrial scrap at BHEL, Hardwar (UP). Indian J Malariol 30:29-35.
5. Ignoffo CM, Garcia C, Kroha MJ, Fukuda T, Couch TL. 1981. Laboratory tests to evaluate the potential efficacy of Bacillus thuringiensis var. israelensis for use against mosquitoes. Mosq News 4:85-93.
6. Kar I, Eapen A, Ravindran KJ, Chandrahas RK, Appavoo NC, Sadanand AV, Dhanaraj B. 1997. Field evaluation of Bacillus sphaericus H5a5b and Bacillus thuringiensis var. israelensis H-14 against the bancroftian filariasis vector Culex quinquefasciatus, Say in Chennai, India. Indian J Malariol 34:25-36.
7. Kumar A, Sharma VP, Thavaselvam D, Sumodan PK. 1995. Control of Anopheles stephensi breeding in construction sites and abandoned overhead tanks with Bacillus thuringiensis var. israelensis. J AmMosq Control Assoc 11:86-89.
8. Manonmani AM, Hoti SL, Balaraman K. 1987. Isolation of mosquito-pathogenic Bacillus thuringiensis strain from mosquito breeding habitats in Tamil Nadu. Indian J Med Res 86:462-468.
9. Mulla MS. 1971. Control of Chironomid midges in recreational lakes. J Econ Entomol 64:300-307.
10. Mulla MS. 1991. Biological control of mosquitoes with entomopathogenic bacteria. Proceedings of the IV National Vector Control Symposium, Taichang, Taiwan. Chinese J Entomol (Special Publication No. 6), 93-103.
11. Mulligan FS, Schaefer CH, Wilder WH. 1980. Efficacy and persistence of Bacillus sphaericus and B. thuringiensis H-14 against mosquitoes under laboratory and field conditions. J Econ Entomol 73:684-688.
12. Priest FG. 1992. Biological control of mosquitoes and other biting flies by Bacillus sphaericus and Bacillus thuringiensis. J Appl Bacteriol 72:357-369.
13. Shukla RP, Kohli VK, Ojha VP. 1997. Larvicidal efficacy of Bacillus sphaericus H5a 5b and Bacillus thuringiensis var. israeliensis H-14 against malaria vectors in Bhabar area, District Naini Tal, U.P. Indian J Malariol 34:208-212.
14. Siegel JP. 2001. A review of the mammalian safety of Bacillus thuringiensis-based insecticides. J Invertebr Pathol 77:13-21.
15. Sun CN, Georghious GP, Weis K. 1980. Toxicity of Bacillus thuringiensis var israelensis to mosquito larvae variously resistant to conventional insecticides. Mosq News 40:614-618.
16. WHO [World Health Organization]. 1982. Biological control of vectors of disease. Sixth Report of WHO Expert Committee on Vector Biology and Control, Geneva. Tech Rep Ser 679 1-39.